Abstract
Chronic daily headache (CDH) is a category of headaches that affects 4% of the general population. While it does not have recognition in the current version of the International Classification of Headache Disorders (ICHD 3), it is a well-recognized clinical entity among headache specialists, and has been defined by Silberstein and Lipton as a headache lasting 15 or more days per month for at least three consecutive months. The majority of CDH is represented by transformed or chronic migraine (CM) and chronic tension-type headaches (CTTH). However, Hemicrania Continua (HC), Chronic Cluster (CC), and New Daily Persistent Headache (NDPH) are also included in this headache category (Headache Classification Committee of the International Headache Society (IHS), Cephalalgia. 33(9):629–808, 2013). Common comorbidities that are associated with CDH include medication overuse headaches, and psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD), as well as the myriad of comorbidities associated specifically with CM (Tzu-Hsien, Update of inpatient treatment for refractory chronic daily headache. Berlin: Springer Science; 2015). The best approach to treatment of CDH is a multidisciplinary one that includes medications, as well as non-pharmacologic therapies. Chronic daily headache remains a challenge for headache specialists and other clinicians, and accounts for more than 85% of the economic burden of headache on society (Soo-Jin, Outcome of chronic daily headache or chronic migraine. Berlin: Springer Science; 2015). Since there is no cure at this time, the goal of treatment remains reduction in the frequency, severity, and duration of headaches, with improvement in quality and function of life and reduced disability. This would create a positive economic impact on society through decreased costs and burden of disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tzu-Hsien L. Update of inpatient treatment for refractory chronic daily headache. Berlin: Springer Science; 2015. Read by QxMD Icon Web. 07 May 2017
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edn. (beta version). Cephalalgia. 2013;33(9):629–808. https://doi.org/10.1177/0333102413485658.
Lenaerts Marc EP, James R. Couch, Shweta Teckchandani, and Shuu-Jiun Wang. “Chronic daily headache”. Medlink Neurol. 2016.
Silberstein, S. D., et al. “Classification of Daily and near-Daily Headaches: Field Trial of Revised IHS Criteria.” Neurology. 1996;47(4):871–5.
Yancey J, Sheridan R, Koren KG. Chronic daily headache: diagnosis and management. Am Fam Physician. 2014;89(8):642–8.
Soo-Jin C. Outcome of chronic daily headache or chronic migraine. Berlin: Springer Science; 2015.
Murinova N, Krashin D. Chronic daily headache. Phys Med Rehabil Clin N Am. 2015;26(2):375–89.
Volcy-Gomez M Chronic daily headache: I. Diagnosis and pathophysiology. Read by QxMD Icon. N.p., 2005, Curr Neurol Neurosci Rep. Mar 2001;1(2):118–24.
Cho SJ, Chu MK. Risk factors of chronic daile headache or chronic migraine. Curr Pain Headache Rep. 2015;19:465.
Mercante JP, Peres MF, Guendler V, et al. Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr. 2005;63(2A):217–20.
Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2015;36(4):371–86.
Garza I, Schwedt TJ. Diagnosis and management of chronic daily headache. Semin Neurol. 2015;30(2):154–66.
Bloudek LM. Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain. 2012;13(5):361–78. https://doi.org/10.1007/s10194-012-0460-7. Published online 2012 May 29PMCID: PMC3381065
Silberstein S, Mathew N, Saper J, for the Botox Migraine Clinical Research Group. Botulinum toxin a as a migraine preventive treatment. Headache. 2000;40:445–50.
Tepper D, Traduzido por Marcelo MV. Onabotulinum A (Toxina OnabotulÃnica Do Tipo A, Botox®). Headache. 2014;54(4):791–2.
Barton PM, Schultz GR, Jarrell JF, Becker WJ. A flexible format interdisciplinary treatment and rehabilitation program for chronic daily headache: patient clinical features, resource utilization and outcomes. Headache. 2014;54(8):1320–36.
Jensen R. Diagnosis, epidemiology, and impact of tension-type headache. Curr Pain Headache Rep. 2003;7(6):455–9.
Verhagen AP. Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review. Fam Pract. 2010;27(2):151–65.
Jackson JL, Shimeall W, Sessums L, DeZee KJ, Becher D, Diemer M, Berbano E, O'Malley PG. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.
Cohen GL. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache. 1997;37(7):433–6.
Saper JR. Chronic daily headache: transformational migraine, chronic migraine, and related disorders. Curr Neurol Neurosci Rep. 2008;8(2):100–7.
Holroyd KA, Labus JS, Carlson B. Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain. 2009;143(3):213–22.
Tella BA, Unubum EV, Danesi MA. The effect of tens on selected symptoms in the management of patients with chronic tension type headache: a preliminary study. Nig Q J Hosp Med. 2008;18(1):25–9.
Espí-López GV, Arnal-Gómez A, Arbós-Berenguer T, González ÁAL, Vicente-Herrero T. Effectiveness of physical therapy in patients with tension-type headache: literature review. J Jpn Phys Ther Assoc. 2014;17(1):31–8.
Karadas O, Gül HL, İnan LE. Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension-type headache. J Headache Pain. 2013;14:44.
Linde K. Acupuncture for the prevention of tension-type headache. Chichester, UK: Wiley. John Wiley & Sons, Ltd; 2016.
Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia. 2015;21(9):874–7.
Peres MFP, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, Young WB. Hemicrania continua is not that rare. Neurology. 2001;57(6):948–51.
Rozen TD. Melatonin responsive hemicrania continua. Headache. 2006;46(7):1203–4.
Peres MF, Silberstein SD. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache. 2002;42(6):530–1.
Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia. 2007;27(2):153–7.
Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg. 2008;110(1):88–91.
Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. 2008;7(11):1001–12.
Garza I, Cutrer F. Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type a. Cephalalgia. 2009;30:500–3.
Obermann M, Holle D, Naegel S, Burmeister J, Diener H-C. Pharmacotherapy options for cluster headache. Expert Opin Pharmacother. 2015;16(8):1177–84.
Ãzge A. Chronic daily headache in the elderly. Curr Pain Headache Rep. 2013;17:12.
May A, Leone M, Áfra J, Linde M, Sándor PS, Evers S, Goadsby PJ. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13(10):1066–77.
Becker WJ. Cluster headache: conventional pharmacological management. Headache. 2013;53(7):1191–6.
Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache. JAMA. 2009;302(22):2451.
Law S, Derry S, Andrew Moore R. Triptans for acute cluster headache. Cochrane Database Syst Rev. 2010;7:CD008042.
Ekbom K, Je H. Cluster headache: aetiology, diagnosis and management. Headache. 2003;43(3):307–8.
Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5(1):83–91.
Leone M, D'Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A. Verapamil in the prophylaxis of episodic cluster headache: a double blinded study versus placebo. Neurology. 2000;54(6):1382–5.
Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol. 2008;21(3):323–30.
Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, Manzoni Gc, Nappi G. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411–7.
Nierenburg H, Newman LC. Update on new daily persistent headache. Curr Treat Options Neurol. 2016;18(6):25.
Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol. 2004;31:122–5.
Sheikh HU. Approach to chronic daily headache. Curr Neurol Neurosci Rep. 2015;15(3):4.
Rozen T. New daily persistent headache: an update. Curr Pain Headache Rep. 2014;18(7):431.
Tepper D. New daily persistent headache. Headache. 2016;56(7):1249–50.
Joshi SG, Mathew PG, Markley HG. New daily persistent headache and potential new therapeutic agents. Curr Neurol Neurosci Rep. 2014;14(2):425.
San-Emeterio EP, Hurlé MA. Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice. Neurosci Lett. 2006;403:276–9.
Chiappedi M, Mensi MM, Termine C, Balottin U. Psychological therapy in adolescents with chronic daily headache. Curr Pain Headache Rep. 2015;20:1.
Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: challenges in clinical practice. Headache. 2005;45(S1):S74–85.
Eccleston C, Fisher E, Craig L, Duggan GB, Rosser BA, Keogh E. Psychological therapies (internet-delivered) for the management of chronic pain in adults. Cochrane Database Syst Rev. 2014;2:CD010152.
Martin PR, Forsyth MR, Reece J. Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther. 2007;38(4):350–63.
Marcus DA, Scharff L, Mercer S, Turk DC. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia. 1998;18(5):266–72.
Glauser J. Assessment and management of migraine headaches–Primary care reports–Oct 01, 2012. Emergency medicine reports, 2012.
Garza I, Swanson JW. Prophylaxis of migraine. Neuropsychiatr Dis Treat. 2006;2(3):281–91.
Tzu-Hsien L. Neural plasticity in common forms of chronic headache. Neural Plast. 2015;2015:205985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Teckchandani, S., Cowan, R. (2019). Chronic Daily Headache: Do We Know It When We See It?. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-91491-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91490-9
Online ISBN: 978-3-319-91491-6
eBook Packages: MedicineMedicine (R0)